Radcliffe Capital Management’s Healthwell Acquisition Corp. I Class A Common Stock HWEL Stock Holding History

Radcliffe Capital Management’s Portfolio HWEL Stock Details HWEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-475,380	Closed	-$4.94M	–	426
2023 Q3	$4.94M	Sell	475,380 -1,117,273	-70%	-$11.5M	0.61%	50
2023 Q2	$16.4M	Sell	1,592,653 -237,477	-13%	-$2.43M	1.39%	11
2023 Q1	$18.6M	Sell	1,830,130 -632	-0%	-$6.36K	1.16%	12
2022 Q4	$18.1M	Hold	1,830,762	–	–	0.57%	14
2022 Q3	$17.8M	Hold	1,830,762	–	–	0.43%	14
2022 Q2	$17.7M	Hold	1,830,762	–	–	0.41%	16
2022 Q1	$17.7M	Hold	1,830,762	–	–	0.4%	18
2021 Q4	$17.7M	Buy	+1,830,762	New	+$17.7M	0.46%	19

Radcliffe Capital Management's HWEL Position: Q4 2023 in Review

Radcliffe Capital Management sold out of Healthwell Acquisition Corp. I Class A Common Stock (HWEL) in Q4 2023, closing a stake of 475,380 shares — an estimated $4.94M sold.

Radcliffe Capital Management first reported a position in HWEL in Q4 2021 and held it in 8 quarters. The position peaked at $18.6M in Q1 2023. 0 funds tracked by Wall St. Rank hold HWEL as of Q4 2023.

Radcliffe Capital Management reported no remaining Healthwell Acquisition Corp. I Class A Common Stock position as of Q4 2023 after selling out during the quarter.
Radcliffe Capital Management sold 475,380 Healthwell Acquisition Corp. I Class A Common Stock shares in Q4 2023, an estimated $4.94M.
Radcliffe Capital Management first reported a position in Healthwell Acquisition Corp. I Class A Common Stock in Q4 2021 and held it in 8 quarters.
Radcliffe Capital Management's Healthwell Acquisition Corp. I Class A Common Stock position peaked at $18.6M in Q1 2023.
0 funds tracked by Wall St. Rank held Healthwell Acquisition Corp. I Class A Common Stock as of Q4 2023.

Based on Radcliffe Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.